Disruption of genomic neighbourhood at the imprinted IGF<sub>2</sub>-H<sub>19</sub> locus in Beckwith-Wiedemann syndrome and Silver-Russell syndrome by Nativio, Rafaella et al.
        
Citation for published version:
Nativio, R, Sparago, A, Ito, Y, Weksberg, R, Riccio, A & Murrell, A 2011, 'Disruption of genomic neighbourhood
at the imprinted IGF2-H19 locus in Beckwith-Wiedemann syndrome and Silver-Russell syndrome', HumanMolecular Genetics, vol. 20, no. 7, pp. 1363-1374. https://doi.org/10.1093/hmg/ddr018
DOI:
10.1093/hmg/ddr018
Publication date:
2011
Document Version
Publisher's PDF, also known as Version of record
Link to publication
Publisher Rights
CC BY-NC
Copyright The Author 2011. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial
License
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 07. Dec. 2019
Disruption of genomic neighbourhood at the
imprinted IGF2-H19 locus in Beckwith–Wiedemann
syndrome and Silver–Russell syndrome
Raffaella Nativio1,{, Angela Sparago2,{, Yoko Ito1, Rosanna Weksberg3,4, Andrea Riccio2,5,{
and Adele Murrell1,∗,{
1Department of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge, LiKaShing
Centre, Cambridge, UK, 2Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy, 3Program in
Genetic and Genomic Biology and 4Division of Clinical and Metabolic Genetics, Hospital for Sick Children Research
Institute, Toronto, Ontario, Canada and 5Department of Environmental Science, University of Naples 2, Caserta, Italy
Received October 26, 2010; Revised and Accepted January 12, 2011
Hyper- and hypomethylation at the IGF2-H19 imprinting control region (ICR) result in reciprocal changes in IGF2-
H19 expression and the two contrasting growth disorders, Beckwith–Wiedemann syndrome (BWS) and Silver–
Russell syndrome (SRS). DNA methylation of the ICR controls the reciprocal imprinting of IGF2 and H19 by
preventing the binding of the insulator protein, CTCF. We here show that local changes in histone modifications
and CTCF–cohesin binding at the ICR in BWS and SRS together with DNA methylation correlate with the higher
order chromatin structure at the locus. In lymphoblastoid cells from control individuals, we found the repressive
histone H3K9me3 and H4K20me3 marks associated with the methylated paternal ICR allele and the bivalent
H3K4me2/H3K27me3 mark together with H3K9ac and CTCF–cohesin associated with the non-methylated
maternal allele. In patient-derived cell lines, the mat/pat asymmetric distribution of these epigenetic marks was
lost with H3K9me3 and H4K20me3 becoming biallelic in the BWS and H3K4me2, H3K27me3 and H3K9ac together
with CTCF–cohesin becoming biallelic in the SRS. We further show that in BWS and SRS cells, there is opposing
chromatin looping conformation mediated by CTCF–cohesin binding sites surrounding the locus. In normal
cells, lack of CTCF–cohesin binding at the paternal ICR is associated with monoallelic interaction between
two CTCF sites flanking the locus. CTCF–cohesin binding at the maternal ICR blocks this interaction by associ-
ating with the CTCF site downstream of the enhancers. The two alternative chromatin conformations are differ-
ently favoured in BWS and SRS likely predisposing the locus to the activation of IGF2 or H19, respectively.
INTRODUCTION
Chromosome 11p15.5 contains two independently regulated
clusters of imprinted genes. An imprinting control region
(ICR) in each cluster controls monoallelic expression of the
surrounding genes. The ICRs correspond to sequences that
are methylated on one parental allele, also known as differen-
tially methylated regions (DMRs). The telomeric cluster har-
bours the IGF2 and H19 genes and the centromeric cluster
contains, among others, the CDKN1C and KCNQ1OT1
genes. Opposite methylation defects at the ICR controlling
IGF2-H19 lead to the fetal over growth syndrome, Beck-
with–Wiedemann syndrome (BWS, OMIM130650) and the
growth retardation syndrome, Silver–Russell syndrome
(SRS, OMIM180680). BWS is also caused by the loss of
ICR methylation and deregulation in the centromeric cluster
or paternal uniparental disomy (pUPD), which results in aber-
rant methylation at the ICRs of both clusters (reviewed in 1,2).
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The ICR at IGF2 and H19 is normally methylated on the
paternal allele. Methylation is excluded from the maternal
allele by CTCF binding. The presence of CTCF confers an
insulator function upon the ICR, which blocks access of the
IGF2 promoters to the enhancers downstream of the H19
gene (3–5). This function is lost on the methylated paternal
chromosome and this enables IGF2 expression by allowing
the promoters to access the enhancers. In mice, we and others
have shown that the higher order chromatin structure at the
locus differs between maternal and paternal alleles and that
on the maternal allele CTCF mediates a looping structure that
sequesters the enhancers away from the Igf2 promoters (6–9).
Cohesin has recently been shown to colocalize with CTCF at
CTCF-binding sites genome wide (10–13). RNAi-mediated
cohesin and CTCF knockdown experiments indicate that
CTCF is required for cohesin loading, but that CTCF binding
is independent of cohesin. Since cohesin is known to hold two
sister chromatids together, it was postulated that cohesin may
also function to hold different chromatid regions together in
cis to facilitate the formation of chromatin loops. We have
recently shown that CTCF and cohesin mediate intrachromoso-
mal looping interactions at the human IGF2-H19 locus and that
the insulator function of the ICR is determined by its interaction
with other CTCF sites at this locus (14). Cohesin is required to
stabilize such loops. Cohesin also associates with other tran-
scription factor complexes independent of CTCF and may facili-
tate looping interactions between promoters and enhancers in
these instances (15,16).
It has been shown in the mouse that the chromatin associ-
ated with the Igf2-H19 ICR carries allele-specific histone
modifications (17). On one allele, H3K9me3 and H4K20me3
are associated with DNA methylation at the ICR, while
H3K4me2/3 and H3/H4 acetylation are found on the chromo-
some carrying the unmethylated ICR. A functional role of
histone modifications in imprinting control is indicated by
the observation that the KDM1B-directed removal of H3K4
methylation is a prerequisite for establishment of DNA
methylation imprints at maternally methylated ICRs (18).
The effects of abnormal methylation changes at the ICR on
the underlying chromatin and long-range associations with
neighbouring CTCF sites are not known. We used a panel of
BWS and SRS cell lines with aberrant methylation at the
IGF2-H19 ICR to address this question. Our data indicate that
DNA methylation changes at the ICR are accompanied by
allele-specific chromatin changes. Methylation and histone
modifications at the ICR further affect chromatin conformation
between several CTCF–cohesin binding sites at the locus, to
generate contrasting structures in BWS and SRS cells.
RESULTS
Contrasting histone marks at the IGF2-H19 ICR in BWS
and SRS cells
Individuals affected by BWS and SRS display DNA methyl-
ation abnormalities at 11p15.5 ICRs in DNA extracted from
peripheral blood leukocytes (PBLs). Epstein Barr Virus
(EBV)-transformed lymphoblastoid cell lines (EBV-LCLs)
have been shown to maintain DNA methylation at the ICRs
over several passages, indicating that epigenetic methylation
imprints are maintained in these cells (19,20).
We established EBV-LCL from eight BWS patients [five with
IGF2-H19 ICR hypermethylation (ICR-HM) and three with
11p15.5 pUPD] and four SRS patients with IGF2-H19 ICR hypo-
methylation. One of the hypermethylated BWS lines carried a
1.4 kb deletion resulting in the HM of the remaining ICR sequence
(21). DNA methylation at the ICR in these cell lines was very
similar to the originating patient’s PBLs (Supplementary Material,
Fig. S1). It has been shown that the gain of methylation at the
maternal ICR results in biallelic IGF2 activation and H19 silen-
cing, while the loss of ICR methylation is associated with IGF2
silencing and biallelic H19 activation (22,23). Although the
expression of the IGF2 and H19 genes is generally low in
EBV-LCLs, we observed that the SRS cell lines had H19 RNA
levels 2–3-fold higher than the BWS and control cell lines (Sup-
plementary Material, Fig. S2A). By cDNA sequencing, we also
demonstrated biallelic H19 expression in three SRS cell lines
which were informative for transcribed SNPs and biallelic IGF2
expression in one informative BWS cell line (Supplementary
Material, Fig. S2B and C). These results are consistent with the
gain of the insulator function on the paternal chromosome in the
hypomethylated SRS cell lines and the loss of the insulator func-
tion on the maternal chromosome in the BWS cell lines.
The BWS and SRS LCLs were further characterized for
chromatin modifications at the ICR. We performed both allele-
specific and quantitative analyses of DNA recovered after
chromatin immunoprecipitation (ChIP) using H3K9me3,
H4K20me3, H3K27me3, H3K4me2 and H3K9ac antibodies.
The region analysed was located around the sixth
CTCF-binding site of the human IGF2-H19 ICR (hg19
chr11: 2021143–2021271). A SNP (rs10732516) was used
to distinguish the maternal and paternal alleles in non-UPD
heterozygote samples. With the allele-specific ChIP assay,
we first observed that in control EBV-LCLs, the repressive
modifications H3K9me3 and H4K20me3 were enriched on
the DNA-methylated paternal ICR allele, while the permissive
modifications H3K4me2 and H3K9ac were enriched on the
non-DNA-methylated maternal allele (Fig. 1B and
Figure 1. Contrasting histone modifications at the ICR in BWS and SRS cell lines. (A)Diagram illustrating the region of the IGF2-H19 locus analysed. The ICR
is indicated by a grey box and the IGF2 and H19 transcription start sites by bent arrows. The ICR region analysed by ChIP corresponding to the sixth CTCF
target site is depicted in dark grey. The location of the PCR primers and the polymorphic HhaI site is indicated. (B). Allele-specific ChIP analysis of H3K9me3,
H4K20me3, H3K4me2, H3K9ac and H3K27me3 in control (C), hypermethylated BWS and hypomethylated SRS EBV-LCLs. The DNAs extracted from input
(I), non-specific IgG control (M) and specific antibody-bound (C) fractions were PCR amplified and digested with the polymorphic HhaI enzyme to distinguish
the parental ICR alleles. As result of HhaI digestion, the 128 bp PCR product was divided in two co-migrating 64 bp fragments. The relative contribution of the
paternal and maternal alleles in the immunoprecipitated chromatin after normalization to input is indicated below the gels. The results obtained on only one cell
line of each group are shown. Complete results are reported in Supplementary Material, Table S1. (C). Real-time qPCR analysis of the histone marks in control,
BWS and SRS EBV-LCLs. The percentage of input chromatin that was precipitated in the antibody-bound fraction at the ICR was normalized to the value
obtained at a positive control region. Box plots show max., third quartile, median, first quartile and min. values for each group of samples. The BWS includes
a group of three samples with paternal 11p15.5 UPD (pUPD) and a group of five samples with ICR-HM. The SRS samples include a single group of five samples
with ICR hypomethylation (ICR-LM). Note that the control, BWS and SRS samples show significant differences in the histone modifications analysed at the ICR.
ANOVA P-values are indicated.
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Supplementary Material, Table S1). H3K27me3 was also
found preferentially associated with the non-methylated
maternal allele. We observed that in two hypermethylated het-
erozygote BWS cell lines (BWS_03 and BWS_06) and four
hypomethylated heterozygote SRS cell lines (SRS_01,
SRS_05, SRS_06 and SRS_08), the mat/pat asymmetric distri-
bution of the five epigenetic marks examined was abolished or
attenuated (Fig. 1B and Supplementary Material, Table S1).
To better characterize the changes in histone marks at the
ICR, we also measured their overall levels in all our cell
lines using qPCR. Consistent with the demonstrated allele
specificity of the histone marks, we observed that in pUPD
BWS cells the paternal-specific H3K9me3 and H4K20me3
were increased while the maternal-specific H3K4me2,
H3K9ac and H3K27me3 were decreased (Fig. 1C). A
similar pattern was observed in the five BWS lines with
ICR-HM, while opposite results with increased H3K4me2,
H3K9ac and H3K27me3 and decreased H3K9me3 and
H4K20me3 were found in the hypomethylated SRS cells
(ICR-LM).
These results show that the allele-specific histone modifi-
cation status of the ICR is altered along with DNA methyl-
ation in BWS and SRS cells. In BWS, the gain of DNA
methylation is associated with the gain of H3K9me3 and
H4K20me3 and the loss of H3K4me2, H3K9ac and
H3K27me3 on the maternal allele. In SRS, the loss of DNA
methylation is associated with the loss of H3K9me3 and
H4K20me3 and the gain of H3K4me2, H3K9ac and
H3K27me3 on the paternal allele. The results also show that
a bivalent H3K4me2/H3K27me3 mark together with
H3K9ac is present on the unmethylated maternal allele in
control cells. These marks are reduced in the BWS cells,
and increased becoming biallelic in the SRS cells.
CTCF and cohesin binding in BWS and SRS cells
Having established that opposite changes in histone marks
occur at the IGF2-H19 ICR in BWS and SRS cells, we
looked at the binding of CTCF and cohesin. Allele-specific
ChIP showed that CTCF and the cohesin subunits RAD21
and SMC3 were preferentially associated with the non-
methylated maternal allele in control cells (Fig. 2A and Sup-
plementary Material, Table S2). However, this allele-specific
distribution was lacking or attenuated in the heterozygote
hypermethylated BWS and hypomethylated SRS cells. The
qPCR analysis demonstrated that the binding of CTCF and
cohesin subunits to the ICR was decreased in all hypermethy-
lated BWS cells as well as pUPD BWS, but increased in hypo-
methylated SRS cells (Fig. 2B), indicating that CTCF and
associated cohesin were lost from both parental alleles in
BWS and acquired on both alleles in SRS.
We then tested CTCF and cohesin binding at the CTCF sites
upstream and downstream of the IGF2-H19 locus. These
regions have previously been shown to be unmethylated and
to bind CTCF and cohesin on both alleles (14). Supplementary
Material, Figure S3 indicates that CTCF and cohesin were
both present at the CTCF site upstream of IGF2 (CTCF
AD), at the centrally conserved domain (CCD) and the
CTCF site downstream of the H19 endoderm and mesoderm
enhancers (CTCF DS), in the normal as well as all the BWS
and SRS cell lines, without significant binding differences.
These results indicate that binding of CTCF–cohesin to
CTCF AD, CCD and CTCF DS is not affected by the DNA
methylation and chromatin changes occurring at the
IGF2-H19 ICR in BWS and SRS.
CTCF-mediated chromatin conformation at the IGF2-H19
locus in normal and pUPD cell lines
We previously observed long-range interactions between the
CTCF sites in the IGF2-H19 region with the ICR interacting
monoallelically with the CTCF DS in an adult epithelial
breast cell line (14). We now examined the looping profile
of a normal neonate fibroblast cell line (HS27), which had
two informative SNPs in the CTCF DS site which enabled
us to assign parental-specific interactions to the CTCF DS
loops by sequencing the 3C products. Using 3C anchors at
the ICR, the enhancer and the two CTCF sites flanking the
locus (CTCF AD and CTCF DS), we found looping profiles
similar to those we previously reported (Supplementary
Material, Fig. S4). Consistent with previous results (14), we
found that the CTCF DS associates monoallelically with the
ICR (Fig. 3). Unexpectedly, however, the CTCF DS was
found to interact monoallelically also with other sites at the
locus. Specifically, CTCF DS site associates with the CTCF
AD and CCD sites on one chromosome and with the ICR on
the reciprocal chromosome (Fig. 3C). Thus, the ICR affects
the allele-specific interactions of the surrounding CTCF sites
at the locus. Since the ICR is methylated on the paternal
allele, it is likely that the CTCF DS association with the
ICR is on the maternal allele, and the CTCF DS association
with the CTCF AD site is on the paternal allele.
We therefore used a pUPD BWS EBV-LCL cell line to
confirm that the associations between the CTCF AD and the
CTCF DS are on the paternal allele as predicted. Using
the CTCF DS and the ICR as anchors, the 3C profiles of the
EBV-LCL control cell line were shown to be remarkably
similar to those observed in the HS27 fibroblast and adult
breast epithelial cell lines (data not shown). Figure 4B and
C shows the topology of the interactions in the pUPD cells.
Compared with the control cell line, the association between
the CTCF DS and the CCD or the CTCF AD is stronger,
whereas the CTCF DS association with the ICR and the enhan-
cer is weaker (Fig. 4B). These results confirm that the CTCF
DS associates with the ICR on the maternal chromosome
and with the CTCF AD and the CCD on the paternal chromo-
some. This was also shown reciprocally, when we placed our
3C anchor at the ICR region, where very little CTCF was
bound (Fig. 4C, see also Fig. 2B). Similar to the control cell
lines, a weak association was evident between the ICR and
the CTCF AD, which could indicate a non-CTCF-mediated
interaction between these regions or represent an indirect
effect of the CTCF DS–AD interaction. These results corrobo-
rate and further clarify our previous interpretation of allele-
specific long-range chromatin interactions at the locus. Since
both the endoderm and mesoderm enhancers are close to the
CTCF DS, it is possible that the CTCF DS directs the enhan-
cers to the IGF2 or H19 promoters through its association with
different CTCF sites on the paternal and maternal chromo-
somes. The mesoderm enhancers are 5 kb downstream of the
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endoderm enhancers and it is therefore possible that the enhan-
cers recruit tissue-specific transcription factors to mediate
transcription, once they have been brought into proximity of
the promoters through the CTCF DS–AS interaction.
CTCF-mediated chromatin conformation in BWS and SRS
cell lines with ICR DNA methylation defects
The BWS and SRS EBV-LCL allowed us to investigate the
relationship between DNA methylation and histone marks
and higher order chromatin conformation at the IGF2-H19
locus. We characterized three BWS cell lines with ICR-HM
and two SRS cell lines with ICR hypomethylation for chroma-
tin looping conformation. Figure 5B shows the average pro-
files of the BWS cases, with the CTCF DS as the 3C anchor
compared with the baseline normal cell line. Similar to
results obtained with the pUPD cells, we found that inter-
actions with the CCD and the CTCF AD sites were increased
while that with the ICR was decreased compared with the
control cell lines. Using the ICR as an anchor, associations
of similar intensity to the control were detected between the
ICR and the CTCF AD, and the weaker association was
detected between the ICR and CTCF DS region (Fig. 5C).
In contrast to the BWS, the SRS cell lines showed a strong
association at the ICR when the CTCF DS was used as an
anchor and a reciprocal strong association at the CTCF DS
when the ICR was used as an anchor (Fig. 6B and C).
However, with both anchors, peaks detected at the CTCF
AD were similar to those of control cell lines. Overall, these
results demonstrate that higher order chromatin conformation
of the IGF2-H19 locus correlates with DNA methylation and
histone mark deposition at the IGF2-H19 ICR. As a result of
Figure 2. Differential CTCF and cohesin binding at the ICR in BWS and SRS cell lines. (A). Allele-specific ChIP analysis of CTCF, RAD21 and SMC3 binding
in control (C1), hypermethylated BWS and hypomethylated SRS EBV-LCLs. The relative contribution of the maternal and the paternal ICR alleles in the immu-
noprecipitated chromatin was determined as in Figure 1 (A). The results obtained on only one cell line of each group are shown. Complete results are reported in
Supplementary Material, Table S2. (B) Real-time qPCR analysis of CTCF, RAD21 and SMC3 binding. The percentage of input chromatin that was precipitated
with CTCF, RAD21 and SMC3 antibodies at the ICR was determined and is indicated as in Figure 1B. Note that the control, BWS and SRS samples show
significant differences in the CTCF and cohesin binding at the ICR. ANOVA P-values are indicated.
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opposite CTCF–cohesin binding and histone modifications,
different long-range interactions are established in BWS and
SRS and are likely to influence IGF2-H19 expression in a reci-
procal manner.
DISCUSSION
We have previously shown that chromatin looping interactions
between CTCF sites at the human IGF2-H19 locus are stabil-
ized by cohesin in an adult breast epithelial cell line (14). Our
current analysis utilizing BWS and SRS LCLs derived from
patients with pUPD and methylation defects at the ICR has
enabled us to assign specific patterns of histone modifications
and chromatin looping profiles to maternal or paternal alleles
and to determine the influence of the ICR on chromatin con-
formation at the locus.
In the first instance, we were able to demonstrate that in
humans, as in the mouse, histone modifications mark the
IGF2-H19 ICR in a parent of origin-specific manner, with
the permissive H3K4me2 and H3K9ac on the
non-DNA-methylated maternal allele and the repressive
H3K9me3 and H4K20me3 on the DNA-methylated paternal
allele. Unexpectedly, the repressive H3K27me3 was preferen-
tially associated with the non-DNA-methylated allele, thus
creating a ‘bivalent domain’ at the maternal ICR. Enrichment
of H3K27me3 at the non-DNA-methylated allele has been pre-
viously reported for other ICRs, and this histone mark is
believed to be associated with the developmental regulation
of linked transcripts rather than with imprinting control (24–
26). However, data obtained by the ENCODE Project and
available from the UCSC hg18 Genome Browser show that
H3K27me3 is present at the IGF2-H19 ICR in several cell
lines including some in which H19 is expressed (e.g. H1ES),
thus indicating that the bivalent mark does not correlate with
cell specificity or expression of the nearby H19 gene (Sup-
plementary Material, Fig. S5). It is relevant to note that simi-
larly to other bivalent domains, the IGF2-H19 ICR is
frequently hypermethylated in cancer cells (27).
In the BWS and SRS cells, the allele-specific histone marks
follow the DNA methylation changes of the IGF2-H19 ICR.
The epigenetic asymmetry observed in control cells was lost
when the ICR was hyper- or hypomethylated with reciprocal
consequences on the occurrence of the histone marks. In par-
allel with DNA methylation and histone modifications, CTCF
binding at the ICR also changed in BWS and SRS cells and
this in turn affected cohesin recruitment. CTCF binding is
known to be inhibited by DNA methylation in vitro (3).
However, the local heterochromatinization of the paternal
ICR allele brought about by H3K9me3 and H4K20me3 may
also have a role in the control of the allele-specific interaction
with non-histone proteins and/or contribute to the asymmetric
higher order chromatin structure of the locus.
It is known that DNA methylation at the ICR determines
methylation at somatic DMRs within the IGF2 locus presum-
ably through long-range interactions. So we examined whether
CTCF binding at the ICR affects CTCF binding and recruit-
ment of cohesin to surrounding CTCF sites. Our data show
that CTCF binding and recruitment of cohesin at sites other
than the ICR is independent of the methylation state at the
ICR. The CTCF sites at the IGF2-H19 locus other than the
ICR are unmethylated and bind CTCF and cohesin on both
alleles.
Figure 3. Allele specificity of looping associations with the CTCF site downstream of the enhancers. (A)Locus with the position of BamHI sites, and
CTCF-binding sites relative to enhancers and genes. (B) Schematic of monoallelic interactions with the CTCF DS site. (C) Heterozygous SNPs in the
CTCF DS enabled the analysis of the allele specificity in the HS27 cell line. The CTCF DS interacts with the CTCF AD and CCD on the ‘AC’ allele and
with the ICR and enhancers on the ‘GA’ allele indicating that the CTCF DS interactions are monoallelic.
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In our control lymphoblastoid and fibroblast cell lines, the
chromatin conformation profiles for loops mediated by associ-
ations between CTCF-binding sites at the locus were found to
be similar to those found previously in breast epithelial cells
(14). SNP analysis in the fibroblast cell line indicates that
the biallelic CTCF site downstream of the enhancers interacts
allele specifically with the ICR and other biallelic CTCF sites.
In a pUPD BWS cell line, the interactions between the CTCF
DS and the ICR are notably low compared with the flanking
enhancer and the CCD, attesting that the ICR–CTCF DS
association is on the maternal chromosome which is normally
unmethylated at the ICR. In contrast, we found that in pUPD
cells, the CTCF DS associates strongly with the CTCF AD,
indicating that this interaction is specific for the paternal
allele. These novel findings of allele-specific interactions
between CTCF sites outside the imprinted region suggest
that we ought to look at promoter competition and insulator
function slightly differently. One interpretation of our data
would be that enhancers do not track, but that instead they
are brought into the proximity of the promoters through
nearby CTCF interactions. This interpretation would support
a primary looping scaffold model where transcription factors
could dock onto promoters and enhancers which are already
in close proximity. This would explain why there is no differ-
ence in looping profiles between IGF2 expressing and non-
expressing cell lines and why the enhancer–promoter
interactions are weaker than the flanking CTCF-mediated
interactions (14). CTCF binding at the AD, CCD and DS
sites is conserved in the mouse locus (D. Schmidt, unpublished
data), and it is likely that if these sites were included in 3C
analysis in mice, the same loops would be detected as found
in humans.
The 3C profiles of BWS cell lines derived from patients in
which the ICR was hypermethylated had identical profiles to
that of the pUPD cell line, suggesting biallelic CTCF AD–DS
associations and the loss of ICR–DS interaction. Conversely,
the SRS cell lines with hypomethylation at the ICR showed
stronger interactions between the ICR and the CTCF DS.
Interestingly, SRS cells did not lose the CTCF DS–AD inter-
actions suggesting that the ICR–DS loop is the limiting step
Figure 4. Looping profile of EBV-LCL cell line derived from a Beckwith patient with pUPD. (A) Locus as in Figure 3. (B) Looping profile of pUPD compared
with EBV control when the CTCF DS is used as an anchor, showing strong interactions with elements 5′ of the ICR such as the CCD and the CTCF AD. No
interaction is seen with the enhancer or ICR. (C). Using the ICR anchor, no difference is seen in the two cell lines for the ICR–CTCF AD interaction, whereas
the ICR–CTCF DS interaction is absent in the pUPD cell line. The paternally methylated ICR does not interact with the CTCF DS, and the CTCF DS interacts
with the CTCF AD on the paternal allele.
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for IGF2 expression control. A fraction of BWS and SRS
patients do not show any molecular defect at the 11p15.5
ICRs and coding sequences. It will be interesting to see if
mutations or abnormal methylation of the CTCF DS or AD
sites causes defective IGF2-H19 expression in these individ-
uals.
In summary, our data fit the modified model depicted in
Figure 7, where CTCF bound sites, together with cohesin
associate to form alternative looping interactions on the
maternal and paternal chromosomes. CTCF bound to the
ICR blocks interactions between the CTCF DS and CTCF
AD, by inserting a new loop that separates the enhancers
away from the IGF2 promoters. Thus, the allele-specific chro-
matin organization of the ICR determined by its asymmetric
histone marks and DNA methylation appears to be the critical
determinant of the long-range interactions at the locus. CTCF
binding seems to be stable in all cell lines examined by
genome-wide ChIP, which would be consistent with a consti-
tutive CTCF–cohesin scaffold at this locus in all tissues. Upon
this scaffold, the enhancers and promoters are brought into
proximity and are poised for activation subject to recruitment
of the appropriate transcription factors. Localized changes in
the chromatin structure at the ICR differently affect the
parent of origin-specific looping conformation and the
expression potential of IGF2 and H19 in BWS and SRS, repre-
senting the first example of how alteration of transcriptional
genomic neighbourhood can contribute to human disease (28).
MATERIALS AND METHODS
Cell lines
LCLs were established by EBV transformation of PBLs of
individuals affected by BWS and SRS and two normal
Figure 5. Looping profile of cell lines from BWS patients with the gain of methylation at the ICR. (A) Locus as in Figure 3. (B) Looping profile at the locus using
CTCF DS as anchor shows that BWS cell lines have strong interactions between the CTCF DS and the CCD compared with control. (C) Looping profiles at locus
using ICR as anchor, showing weaker interactions between the ICR and the CTCF DS (n ¼ 3 BWS cell lines representing three biological replicates, each sample
being processed thrice as technical replicates).
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controls. Cells were grown in the RPMI 1640 medium sup-
plemented with 15% fetal bovine serum, L-glutamine and anti-
biotics at standard concentration.
DNA methylation analysis
ICR DNA methylation was determined by pyrosequencing and
bisulphite treatment coupled with restriction enzyme digestion
(COBRA) as previously described (14,29). For COBRA, after
DNA modification with sodium bisulphite, the CTS6 region
(surrounding the sixth CTCF-binding site of the ICR) was
PCR amplified, the product digested with BstUI and the
restriction fragments separated on a non-denaturing 6% poly-
acrylamide gel.
Expression analysis
RNAs were extracted from cultured EBV-LCL by use of
Trizol (Invitrogen). For the detection of the H19 and IGF2
transcripts, 2 mg of total RNA was used for the cDNA
synthesis with the QuantiTect Reverse Transcription Kit
(Qiagen), according to the protocol of the manufacturer. Quan-
titative expression was determined by real-time PCR using iQ
SYBR Green Supermix (BioRad). Reactions were run on a
CFX96 Real-Time System + C1000 Thermal Cycler
(Biorad). Two independent cDNA preparations from each
RNA sample were analysed in triplicate. For the allele-specific
analysis of H19 and IGF2, polymorphisms were typed by PCR
amplification of DNA and cDNA, followed by sequencing. A
nested PCR was required for the cDNA amplification of both
transcripts. All primer sequences and PCR conditions are
available upon request.
Chromatin immunoprecipitation (ChIP)
Chromatin from about 80 million cells was prepared as
described previously (30) and 100 mg was used for each
immunoprecipitation reaction with Protein A Agarose/
Salmon Sperm DNA (Millipore, 16-157) and specific anti-
body. H3K9me3 (07-442), H3K4me2 (07-030), H3K4me3
Figure 6. Looping profile of cell lines from SRS patients with the loss of methylation at the ICR. (A) Locus as in Figure 3. (B) Looping profile at the locus using
CTCF DS as anchor shows that SRS cell lines have strong interactions between the CTCF DS and the ICR compared with control. (C) Looping profiles at the
locus using ICR as anchor, showing strong interactions between the ICR and the CTCF DS (n ¼ 2 SRS cell lines representing three biological replicates, each
sample being processed thrice as technical replicates).
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(07-473), H3K27me3 (07-449), H3K9ac (07-352), H4ac
(06-598) and CTCF (07-729) antibodies were provided by
Millipore. Antibodies against H4K20me3 (AB9053), RAD21
(AB992) and SMC3 (AB9263) were obtained from
ABCAM. For each ChIP, a fraction of the input chromatin
(1%) was also processed for DNA purification and a mock
immunoprecipitation with a neutral, unrelated IgG antiserum
was carried out in parallel.
Allele-specific analysis of immunoprecipitated chromatin
In the input, mock and antibody-bound fractions of cell lines
heterozygote for the HhaI RFLP rs10732516, parental alleles
were distinguished by enzymatic digestion of an HOT-STOP
32P-dCTP-labeled PCR product. The DNA region across the
polymorphic site was amplified using the following primer
pair: For 5′-TCCTTCGGTCTCACCGCCTG-3′, Rev
5′-TTCCACGGGCGAACCCCAGT-3′. Products were
resolved on 8% polyacrylamide gels and the relative band
intensities were quantified by using ImageQuant (Molecular
Dynamics).
qPCR analysis of immunoprecipitated chromatin
Levels of immunoprecipitated chromatin at specific loci were
determined by quantitative real-time PCR amplification,
Figure 7. Summary of human allele-specific loops and changes in BWS and SRS patients. (A) Locus showing CTCF and cohesin complexes as blue circles, the
CTCF-binding sites as bars and the enhancer as an oval. Position of the IGF2 and H19 genes are shown with arrows. The CTCF AD and CCD were previously
shown to interact on both alleles. The unmethylated ICR interacts with the CTCF DS on the maternal allele. When the ICR is methylated, the CTCF DS interacts
with the CTCF AD site on the paternal allele (B). Proposed model for the maternal allele showing that the ICR and CTCF DS interact and sequester the enhancers
into proximity of the H19 promoter—gain of methylation and heterochromatic conformation at the ICR in BWS patients results in the CTCF DS site interacting
with the CTCF AD and CCD. The CTCF DS essentially drags the enhancer into the vicinity of the IGF2 promoters. (C) Proposed model for the paternal allele
where CTCF hub is formed between the CTCF sites at the locus. Methylation at the ICR excludes it from CTCF binding and keeps it outside of the CTCF hub. In
SRS patients, the loss of heterochromatic marks enables the ICR to interact with the CTCF DS.
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carried out with the C1000 Thermal Cycler CFX96 Real-Time
System, using the iQ SYBR Green Supermix (Biorad,
170-8882). Each PCR was run in triplicate and protein
binding was quantified as a percentage of total input material,
calculated as described by Wierzbicki (protocol available at:
http://www.mcdb.lsa.umich.edu/labs/wierzbicki/protocols.php).
The same primer pair was used for both allele-specific and
qPCR analyses. In order to compare ChIP levels of different
cell lines, precipitation levels obtained at the analysed region
for each antibody were normalized to the level obtained on a
positive control region. An heterochromatic satellite region on
chromosome 4 was used as positive control for the H3K9me3
and H4K20me3 binding: For 5′-CTGCACTACCTGAAGA
GGAC-3′, Rev 5′-GATGGTTCAACACTCTTACA-3′; the
GAPD promoter was the positive control for the H3K4me2
and H3K9ac binding: For 5′-CAATTCCCCATCTCAGT
CGT-3′, Rev 5′-GCAGCAGGACACTAGGGAGT-3′; the
MYO-D promoter was the positive control for the H3K27me3
binding: For 5′-ACGGCTCTCTCTGCTCCTTT-3′, Rev
5′-GAGTGCTCTTCGGGTTTCAG-3′; an intergenic chromo-
some 6 region (region 25), described by Wendt et al. (13),
was used for CTCF and cohesin binding: For
5′-CAGCTCTGTGTCCTGTCTTATCC-3′, Rev 5′-CAGCTA
TAATTGATGAAGAGGCG-3′. Normalized values of enrich-
ment were grouped according to molecular defect at 11p15.5
and graphed as box plot.
Quantitative chromatin conformation capture (q3C)
q3C was performed as described previously (31–34) with the
following modifications. Subconfluent cells from a 15 cm2
plate were fixed in 1% formaldehyde for 10 min at 378C.
After washing out the formaldehyde with ice-cold PBS, cells
were collected and suspended in 1 ml lysis buffer (50 mM
Tris–HCl pH 8, 1% SDS, 10 mM EDTA + 1/500 Protease
Inhibitor Cocktail (PI) (P8340, Sigma)]. The cells were
passed five times through a syringe needle and incubated on
ice for 10 min. Nuclei were collected by centrifugation at
3500 rpm for 5 min. 1.5 × 106 nuclei were resuspended in
300 ml of 1X Buffer 3 [R0136M, New England Biolabs
(NEB) with added protease inhibitors (P8340, Sigma) and
1.8% Triton X-100 (T8787, Sigma)]. Nuclei were digested
overnight with 1000 U of BamHI (R0136M, NEB) in a
300 ml reaction volume.
Ligation was carried out at 2.5 ng/ml final concentration of
digested chromatin in a 1.5 ml reaction volume of T4 ligase
buffer (B0202S, NEB) containing 3200 U of T4 ligase
(M0202L, NEB). A further overnight digestion step with
1000 U of EcoRI (R0101M, NEB), which cuts outside the
hybrid ligation products, was incorporated prior to reversal
of crosslinks to shorten the size of the 3C template and
increase the PCR efficiency. After this step, the samples
were ethanol precipitated. Quality control checks for BamHI
digestion efficiency was assessed by qPCR across each restric-
tion site. The percentage of digestion was determined by com-
paring template amplification of digested (not relegated) and
undigested fractions after normalizing to copy number of
genomic DNA. If digestion efficiency was below 70%, the
chromatin was discarded.
3C primers design and qPCR
3C qPCR primers flanking BamHI restriction sites were as pre-
viously described (14). PCR efficiency of each primer combi-
nation was assessed on a 3C PCR standard. Ten thousand
copies of 3C template for each primer combination (measured
by qPCR amplification of a region excluding BamHI sites)
were then used in a qPCR reaction for the 3C analysis. A
384-well real-time machine (7900HT Fast Real time PCR
system, Applied Biosystems) was used for the PCR amplifica-
tion as previously described (14). Quantification of 3C inter-
actions was based on standard curves for each primer set.
3C standard template preparation
A stock of PCR standard template was prepared similar to that
described previously (34) by amplification of 36 genomic
regions across BamHI RSs in the IGF2-H19 locus on commer-
cially obtained genomic DNA (Becton Dickinson). These
amplicons were column purified (DNA Clean a Con-
centratorTM 25 Kit, Zymo Research) and quantified using a
Picogreen assay. Equimolar amounts of amplicons were
mixed, BamHI digested, re-ligated, purified by ethanol precipi-
tation and dissolved in H2O.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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